Monogram Biosciences, Inc. (Nasdaq: MGRM) announced today that William
D. Young, Chairman of the Board and Chief Executive Officer, is
scheduled to present a corporate overview at the 8th Annual
JMP Securities Research Conference on Monday, May 18 at 11:30 a.m.
Eastern Time (8:30 a.m. Pacific Time) at the Ritz-Carlton Hotel in San
Francisco, California.
To access the live audio broadcast or the subsequent archived recording,
log on to http://www.monogrambio.com
and go to the investor relations section (“Investors/Media” tab) and
click on the “Events & Webcasts” link provided on the sidebar menu on
the page.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering, developing
and marketing innovative products to guide and improve treatment of
serious infectious diseases and cancer. The Company's products are
designed to help doctors optimize treatment regimens for their patients
that lead to better outcomes and reduced costs. The Company's technology
is also being used by numerous biopharmaceutical companies to develop
new and improved antiviral therapeutics and vaccines as well as targeted
cancer therapeutics. More information about the Company and its
technology can be found on its web site at www.monogrambio.com.
Monogram Biosciences, Inc.
Alfred G. Merriweather, 650-624-4576
Chief
Financial Officer
amerriweather@monogrambio.com
or
Feinstein
Kean Healthcare
Jeremiah Hall, 415 677-2700
jeremiah.hall@fkhealth.com
